1. Home
  2. TVRD vs FLIC Comparison

TVRD vs FLIC Comparison

Compare TVRD & FLIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVRD
  • FLIC
  • Stock Information
  • Founded
  • TVRD 2017
  • FLIC 1927
  • Country
  • TVRD United States
  • FLIC United States
  • Employees
  • TVRD N/A
  • FLIC N/A
  • Industry
  • TVRD Biotechnology: Pharmaceutical Preparations
  • FLIC Major Banks
  • Sector
  • TVRD Health Care
  • FLIC Finance
  • Exchange
  • TVRD Nasdaq
  • FLIC Nasdaq
  • Market Cap
  • TVRD 246.5M
  • FLIC 280.5M
  • IPO Year
  • TVRD N/A
  • FLIC N/A
  • Fundamental
  • Price
  • TVRD $28.34
  • FLIC $11.87
  • Analyst Decision
  • TVRD Strong Buy
  • FLIC Buy
  • Analyst Count
  • TVRD 2
  • FLIC 1
  • Target Price
  • TVRD $52.00
  • FLIC $16.56
  • AVG Volume (30 Days)
  • TVRD 48.4K
  • FLIC 67.6K
  • Earning Date
  • TVRD 05-13-2025
  • FLIC 07-24-2025
  • Dividend Yield
  • TVRD N/A
  • FLIC 7.08%
  • EPS Growth
  • TVRD N/A
  • FLIC N/A
  • EPS
  • TVRD N/A
  • FLIC 0.72
  • Revenue
  • TVRD N/A
  • FLIC $85,364,000.00
  • Revenue This Year
  • TVRD N/A
  • FLIC $17.38
  • Revenue Next Year
  • TVRD N/A
  • FLIC N/A
  • P/E Ratio
  • TVRD N/A
  • FLIC $16.49
  • Revenue Growth
  • TVRD N/A
  • FLIC N/A
  • 52 Week Low
  • TVRD $8.13
  • FLIC $9.30
  • 52 Week High
  • TVRD $34.31
  • FLIC $15.03
  • Technical
  • Relative Strength Index (RSI)
  • TVRD N/A
  • FLIC 47.57
  • Support Level
  • TVRD N/A
  • FLIC $11.68
  • Resistance Level
  • TVRD N/A
  • FLIC $12.04
  • Average True Range (ATR)
  • TVRD 0.00
  • FLIC 0.25
  • MACD
  • TVRD 0.00
  • FLIC -0.07
  • Stochastic Oscillator
  • TVRD 0.00
  • FLIC 30.19

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

About FLIC First of Long Island Corporation (The)

First of Long Island Corp is a holding company that provides financial services. It offers services of saving accounts, current accounts, and capital gain accounts. The company also provides lending services, such as commercial and residential mortgage loans, industrial loans, small business credit scored loans, and other credit facilities. In addition, the company provides account reconciliation services, ATM Banking, bill payment, cash management services, mobile banking, online banking, and payroll services to privately owned businesses, professionals, consumers, and public bodies.

Share on Social Networks: